Quick Answer
International Stem Cell CORP reported Net Income of -$418.0 thousand for fiscal year 2025.
International Stem Cell CORP Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$418.0K | -100.0% |
| 2024 | -$209.0K | -59.5% |
| 2023 | -$131.0K | +60.4% |
| 2022 | -$331.0K | +63.2% |
| 2021 | -$899.0K | +67.0% |
| 2020 | -$2.72M | +36.1% |
| 2019 | -$4.26M | -100.1% |
| 2018 | -$2.13M | +64.9% |
| 2017 | -$6.07M | -462.5% |
| 2016 | -$1.08M | +59.1% |
| 2015 | -$2.63M | +78.9% |
| 2014 | -$12.48M | -19.1% |
| 2013 | -$10.48M | -6.6% |
| 2012 | -$9.83M | -7.2% |
| 2011 | -$9.17M | +27.9% |
| 2010 | -$12.72M | -49.5% |
| 2009 | -$8.51M | -29.6% |
| 2008 | -$6.57M | -8.2% |
| 2007 | -$6.07M | +7.8% |
| 2006 | -$6.58M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $57.0K | +145.6% | -55.8% |
| June 30, 2025 | $129.0K | +8.4% | +150.4% |
| March 31, 2025 | -$256.0K | -19.6% | -104.8% |
| September 30, 2024 | -$125.0K | +4.6% | -205.0% |
| June 30, 2024 | $119.0K | -75.8% | +155.6% |
| March 31, 2024 | -$214.0K | -529.4% | -63.4% |
| September 30, 2023 | -$131.0K | +61.8% | -126.6% |
| June 30, 2023 | $492.0K | +24700.0% | +1547.1% |
- International Stem Cell CORP showed a decrease of -100.0% in Net Income compared to the prior fiscal year.
- Over the 2006–2025 period, International Stem Cell CORP’s net income has grown by 93.7% (from -$6.58 million to -$418.0 thousand).
- The most recent figure is from International Stem Cell CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: